Mao Hagihara, Ph.D

miclobiology
Department of Infection Control and Prevention, Aichi Medical University Hospital, Japan., Japan

Poster(s):

• (474) Real-World Experience of the Comparative Effectiveness and Safety of Remdesivir and Combination Therapy (Remdesivir and Monoclonal Antibodies) in Immunosuppressed Patients with Mild to Moderate COVID-19: A Retrospective Single-center Study in a Community Setting
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET